Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Joanna E. Mathy

Combinations of Cyclophilin Inhibitor NIM811 With Hepatitis C Virus NS3-4A Protease or NS5B Polymerase Inhibitors Enhance Antiviral Activity and Suppress the Emergence of Resistance

Antimicrobial Agents and Chemotherapy

Infectious Diseases

Pharmacology

2008

English

Related publications

Antiviral Activity and Resistance Analysis of NS3/4A Protease Inhibitor Grazoprevir and NS5A Inhibitor Elbasvir in Hepatitis C Virus GT4 Replicons

Antimicrobial Agents and Chemotherapy

Infectious Diseases

Pharmacology

2017

English

In VitroAntiviral Activity and Resistance Profile of the Next-Generation Hepatitis C Virus NS3/4A Protease Inhibitor Glecaprevir

Antimicrobial Agents and Chemotherapy

Infectious Diseases

Pharmacology

2017

English

Development of Cell-Based Assays for in Vitro Characterization of Hepatitis C Virus NS3/4A Protease Inhibitors

Antimicrobial Agents and Chemotherapy

Infectious Diseases

Pharmacology

2005

English

Evaluation of the Anti-Hepatitis C Virus Effects of Cyclophilin Inhibitors, Cyclosporin A, and NIM811

Biochemical and Biophysical Research Communications

English

NIM811, a Cyclophilin Inhibitor, Exhibits Potent in Vitro Activity Against Hepatitis C Virus Alone or in Combination With Alpha Interferon

Antimicrobial Agents and Chemotherapy

Infectious Diseases

Pharmacology

2006

English

The Discovery and Development of Boceprevir: A Novel, First-Generation Inhibitor of the Hepatitis C Virus NS3/4A Serine Protease

Journal of Clinical and Translational Hepatology

2013

English

Sequencing Analysis of NS3/4A, NS5A, and NS5B Genes From Patients Infected With Hepatitis C Virus Genotypes 5 and 6

Journal of Clinical Microbiology

Microbiology

2016

English

The Protease Domain Increases the Translocation Stepping Efficiency of the Hepatitis C Virus NS3-4A Helicase

Journal of Biological Chemistry

English

Characterization of Thiobarbituric Acid Derivatives as Inhibitors of Hepatitis C Virus NS5B Polymerase

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Joanna E. Mathy

Combinations of Cyclophilin Inhibitor NIM811 With Hepatitis C Virus NS3-4A Protease or NS5B Polymerase Inhibitors Enhance Antiviral Activity and Suppress the Emergence of Resistance

Related publications

Antiviral Activity and Resistance Analysis of NS3/4A Protease Inhibitor Grazoprevir and NS5A Inhibitor Elbasvir in Hepatitis C Virus GT4 Replicons

In VitroAntiviral Activity and Resistance Profile of the Next-Generation Hepatitis C Virus NS3/4A Protease Inhibitor Glecaprevir

Development of Cell-Based Assays for in Vitro Characterization of Hepatitis C Virus NS3/4A Protease Inhibitors

Evaluation of the Anti-Hepatitis C Virus Effects of Cyclophilin Inhibitors, Cyclosporin A, and NIM811

NIM811, a Cyclophilin Inhibitor, Exhibits Potent in Vitro Activity Against Hepatitis C Virus Alone or in Combination With Alpha Interferon

The Discovery and Development of Boceprevir: A Novel, First-Generation Inhibitor of the Hepatitis C Virus NS3/4A Serine Protease

Sequencing Analysis of NS3/4A, NS5A, and NS5B Genes From Patients Infected With Hepatitis C Virus Genotypes 5 and 6

The Protease Domain Increases the Translocation Stepping Efficiency of the Hepatitis C Virus NS3-4A Helicase

Characterization of Thiobarbituric Acid Derivatives as Inhibitors of Hepatitis C Virus NS5B Polymerase